UBP
TEVA icon

Union Bancaire Privee’s Teva Pharmaceuticals TEVA Stock Holding History

Union Bancaire Privee’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2M Sell
703,968
-37,465
-5% -$1.25M 0.24% 64
2026
Q1 		$20.6M Sell
741,433
-44,839
-6% -$1.44M 0.29% 62
2025
Q4 		$23.7M Buy
786,272
+766,272
+3,831% +$18.9M 0.28% 67
2025
Q3 		$367K Hold
20,000
– – 0.01% 344
2025
Q2 		$335K Hold
20,000
– – ﹤0.01% 343
2025
Q1 		$302K Hold
20,000
– – 0.01% 353
2024
Q4 		$446K Buy
+20,000
New +$364K 0.01% 344

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Union Bancaire Privee's TEVA Position: Q2 2026 in Review

Union Bancaire Privee reduced its Teva Pharmaceuticals (TEVA) stake by 5.1% in Q2 2026, selling an estimated $1.25M and leaving 703,968 shares worth $22.2M. The position accounts for 0.24% of the portfolio, ranked #64.

Union Bancaire Privee first reported a position in TEVA in Q4 2024 and has held it in 7 quarters since. The position peaked at $23.7M in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Union Bancaire Privee held 703,968 shares of Teva Pharmaceuticals worth $22.2M as of Q2 2026.
  • Union Bancaire Privee sold 37,465 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.25M.
  • Teva Pharmaceuticals made up 0.24% of Union Bancaire Privee's portfolio in Q2 2026, its #64 holding.
  • Union Bancaire Privee first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Union Bancaire Privee's Teva Pharmaceuticals position peaked at $23.7M in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.